United States set
language
Menu Shopping cart $0 Search
Distributed product

Glucagon-Like Peptide-2 Human ELISA

  • Regulatory status:RUO
  • Type:Competitive ELISA, Immobilized antibody
  • Other names:GLP-2
  • Species:Human
United States orders are shipped from our US branch, BioVendor, LLC
Cat. No. Size Price


YK141 96 wells (1 kit) $751
PubMed Product Details
Technical Data

Cat # changed from RSCYK141R to YK141

Type

Competitive ELISA, Immobilized antibody

Applications

Serum, Plasma-EDTA, Plasma-Heparin, Plasma-Citrate

Sample Requirements

25 µl/well

Shipping

At ambient temperature. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

0.412–100 ng/ml

Intra-assay (Within-Run)

Human plasma - CV(%) 3.7 - 4.8 Human serum - CV(%) 3.0 - 5.5

Inter-assay (Run-to-Run)

Human plasma - CV(%) 13.0 - 16.4 Human serum - CV(%) 14.3 - 17.5

Spiking Recovery

Human plasma 1 - 89,4 % Human plasma 2 - 86,1 % Human serum 1 - 95,0 % Human serum 2 - 82,6 %

Summary

Research topic

Diabetology - Other Relevant Products

Summary

Proglucagon gene is expressed in both pancreatic A cell and intestinal L cell. Tissue-specific posttranslational processing of proglucagon by prohormone convertase produces different proglucagon derived peptides (PGDPs) in both pancreas and intestine. The most notable pancreatic PGDP is glucagon, whereas intestinal L cell produces several structurally related peptides, including glucagon-like peptide 1 (GLP-1) and 2 (GLP-2), as well as glicentin and oxyntomodulin which contain glucagon sequence in their molecules. Among PGDPs, GLP-2 has been found to show intestinal epithelial proliferation.

Product References (3)

References

  • .
  • .
  • .
Related Products Docs
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
Subscribe to Our Newsletter! Discover News from
BioVendor R&D
Subscribe Now
zavřít